The impact of obesity and metabolic syndrome on alcoholic liver disease
- PMID: 24274871
- PMCID: PMC6130318
- DOI: 10.1016/j.cld.2013.09.006
The impact of obesity and metabolic syndrome on alcoholic liver disease
Abstract
Alcoholic liver disease (ALD) remains a major cause of chronic liver diseases and liver failure. Population-based prospective studies and patient cohort studies have demonstrated that obesity and the metabolic syndrome exacerbate progression of ALD and increase hepatocellular carcinoma (HCC) incidence and mortality. Emerging evidence also suggests a synergism between alcohol and obesity in mortality and HCC incidence. Recognition of these increased risks and detection of early-stage liver disease may offer the opportunity to address these modifiable risk factors and prevent disease progression in these patients.
Keywords: Alcoholic liver disease; Diabetes; Insulin resistance; Metabolic syndrome; Obesity.
Copyright © 2014 Elsevier Inc. All rights reserved.
References
-
- Mandayam S, Jamal MM, Morgan TR. Epidemiology of alcoholic liver disease. Seminars in liver disease. August 2004;24(3):217–232. - PubMed
-
- Corrao G, Ferrari P, Zambon A, Torchio P. Are the recent trends in liver cirrhosis mortality affected by the changes in alcohol consumption? Analysis of latency period in European countries. Journal of studies on alcohol. September 1997;58(5):486–494. - PubMed
-
- Kim WR, Brown RS, Jr., Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology (Baltimore, Md. July 2002;36(1):227–242. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
